In
1940, the British biologist Peter Medawar was called upon to consult on a
severely burned airman whose plane crashed near Medawar’s Oxford home during
the Battle of Britain. This led to a series of studies in which he and a
colleague experimented with skin grafts and their sustainability. They observed
that when the burn victim received a graft of his own skin (an autograft), it
was successfully retained. By contrast, skin grafts from an unrelated donor
failed to graft permanently and were rejected within two weeks; subsequent
grafts were rejected even more rapidly. Medawar suspected that an underlying
immunological reaction was responsible and later found that by suppressing this
reaction with cortisone-like drugs, he could delay the rejection of the graft.
Working
independently during the 1940s, Frank Macfarlane Burnet, an Australian
virologist, was intrigued by immune tolerance in pregnancy, where the fetus and
placenta—both foreign tissues—are not rejected by the maternal immune system.
He introduced the concepts of self and non-self to immunology, which helped to
explain autoimmunity, where the body generates antibodies against its own
tissues, viewing them as non-self and attempting to destroy them.
Burnet
had established the theoretical basis for acquired immunological tolerance. In
1953, Medawar provided experimental supporting evidence for this theory, which
lead to successful transplantation of solid organs, and for which they were
co-recipient awardees of the 1960 Nobel Prize. Medawar established that during
embryonic development, and shortly after birth, immune cells develop that can
destroy foreign (non-self) cells. In his key experiment in 1953, Medawar
injected tissue cells from adult mice (donors) into developing mouse embryos
(recipients). After birth, the recipient mice were able to tolerate skin grafts
from their donors but rejected grafts from other unrelated mice. These results
established acquired immunological tolerance and provided the basis for later
work that developed approaches for suppressing the rejection of organ and
tissue transplants.
No comments:
Post a Comment